Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pilot Open Label Study With Commercial Supplementation (Bioritmon Immuno Defend) in Healthy Subjects

NCT06302842 is registered in ClinicalTrials.gov with Istituto Auxologico Italiano as lead sponsor.

NCT NCT06302842
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06302842 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pilot Open Label Study With Commercial Supplementation (Bioritmon Immuno Defend) in Healthy Subjects
Lead sponsor
Istituto Auxologico Italiano
Phase
Not applicable
Overall status
Completed
Start date
July 1, 2023
Completion date
December 31, 2024
Enrollment
15 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

supportive care